A detailed history of Hobbs Group Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Hobbs Group Advisors, LLC holds 55 shares of EXAS stock, worth $3,196. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Previous 55 -0.0%
Holding current value
$3,196
Previous $2.32 Million 61.23%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$41.33 - $74.26 $2,273 - $4,084
55 New
55 $2.32 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Hobbs Group Advisors, LLC Portfolio

Follow Hobbs Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hobbs Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hobbs Group Advisors, LLC with notifications on news.